---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-368296"
form_type: "8-K"
ticker: "IKT"
cik: "0001750149"
company_name: "Inhibikase Therapeutics, Inc."
filed_at: "2026-08-26T20:05:57+00:00"
generated_at: "2026-08-26T20:07:08.443675+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Inhibikase dismisses CohnReznick, appoints Deloitte as new auditor

## Summary
- Dismissed CohnReznick effective Aug 21, 2026; no disagreements on accounting principles or practices.
- Appointed Deloitte & Touche as independent auditor for FY2026, effective immediately after dismissal.
- CohnReznick's audit reports for FY2024 and FY2025 were unqualified; no adverse or modified opinions.
- Material weakness in internal control over financial reporting disclosed in Q2 2024 was remediated by Q3 2024.
- CohnReznick letter to SEC dated Aug 26, 2026 filed as Exhibit 16.1.

## SEC filing metadata
- accession: 0001193125-26-368296
- form_type: 8-K
- ticker: IKT
- cik: 0001750149
- company_name: Inhibikase Therapeutics, Inc.
- filed_at: 2026-08-26T20:05:57+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750149/000119312526368296/0001193125-26-368296-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750149/000119312526368296/d904831d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-368296
- JSON: https://secwatch.observer/filing/0001193125-26-368296.json
- Plain text: https://secwatch.observer/filing/0001193125-26-368296.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.